A Safety Study of Intraoperative Radiation Therapy Following Stereotactic Body Radiation Therapy and Multi-agent Chemotherapy in the Treatment of Localized Pancreatic Adenocarcinoma

Trial ID: NCT05141513

Interventional - Phase 1 - Active, not recruiting

This study is designed to investigate the safety of intraoperative radiation therapy (IORT) in patients with localized pancreatic cancer undergoing surgical resection after neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT).

Conditions

Interventions

Eligibility

Inclusion criteria

Exclusion criteria

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: ClinicalTrials.gov

Search more clinical trials on myTomorrows